Personalised Treatment for OSA

Launched by UNIVERSITY HOSPITAL, ANTWERP · Apr 3, 2025

Keywords

ClinConnect Summary

Obstructive sleep apnea (OSA) is a sleep disorder characterized by repetitive episodes of partial or complete obstruction of the upper airway during sleep, leading to reduced or completely stopped airflow despite ongoing respiratory efforts. This results in disrupted sleep and intermittent hypoxia. This disorder is estimated to affect 17% of middle-aged women and 34% of middle-aged men \[1\]. Loud snoring, a precursor of OSA, is even more prevalent and is estimated to affect 40-60% of adult people \[2\]. OSA does not only cause symptoms such as excessive daytime sleepiness, loud snoring, an...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • adult patients (age starting from 18 years old)
• • moderate to severe OSA (AHI ≥ 15/h)
• • CPAP-intolerant or non-compliant
• • willing to explore alternative treatment options
• Exclusion Criteria:
• • patients who are still on CPAP therapy
• • pediatric patients
• • newly diagnosed patients who have not had CPAP before
• • patients with AHI ≥ 65 events/h.